Autor/a: Anthony S McLean, professor of intensive care medicine, Benjamin Tang, associate professor of intensive care medicine, Stephen J Huang, associate professor and principal research fellow, intensive car Fuente: BMJ 2015; 350 doi: http://dx.doi.org/10.1136/bmj.h254 Investigating sepsis with biomarkers
Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA.Sepsis syndrome: a valid clinical entity. Methyl-prednislone Severe Sepsis Study Group. Crit Care Med1989;17:389-93.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med2013;39:165-228.
Bryan C, Morris AM, Tomlinson G, Detsky AS. Does this adult patient with suspected bacteremia require blood culture? JAMA2012;308:502-11.
Paran Y, Yablecovitch D, Choshen G, Zeitlin I. C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency department. Crit Care2009;13:R50.
Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis2004;39:206-17.
Phypers B, Pierce JM. Lactate physiology in health and disease. Contin Educ Anaesth Crit Care Pain2006;6:128-32.